FreshPatents.com Logo
Enter keywords:  

Track companies' patents here: Public Companies RSS Feeds | RSS Feed Home Page
Popular terms

[SEARCH]

Dimethyl topics
Physiologic
Hydrochloric Acid
Fresnel Zone
Aberration
Ophthalmic
Liquid Crystal
Imaging System
Pharmaceutically Acceptable Salt
Pharmaceutically Acceptable Salts
Chloric Acid
Tartaric Acid
Fumaric Acid
Antagonist
Bradykinin
Enantiomer

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Dimethyl patents



      
           
This page is updated frequently with new Dimethyl-related patent applications. Subscribe to the Dimethyl RSS feed to automatically get the update: related Dimethyl RSS feeds. RSS updates for this page: Dimethyl RSS RSS


Hexafluorodimethylcarbinol terminated alkane- and alkenethiols

Hexafluorodimethylcarbinol terminated alkane- and alkenethiols

Date/App# patent app List of recent Dimethyl-related patents
11/13/14
20140336420
 System and method for producing gasoline or dimethyl ether patent thumbnailSystem and method for producing gasoline or dimethyl ether
A system or method for producing gasoline or dimethyl ether from natural gas via methanol includes: steam-reforming natural gas to generate reformed gas; synthesizing methanol from the reformed gas; synthesizing gasoline or dimethyl ether from the methanol; and at least one is selected from the group consisting of: pre-reforming natural gas prior to the steam-reforming; recovering carbon dioxide from flue gas generated in the steam-reforming; and preheating combustion air to be supplied to the steam-reforming by using synthesis heat generated in the synthesis of gasoline or dimethyl ether. In addition, an overall energy balance of the system is constructed by using heat recovery from flue gas generated in the steam-reforming, heat recovery from the reformed gas, synthesis heat generated in the synthesis of methanol, synthesis heat generated in the synthesis of gasoline or dme, and heat recovered in the pre-reforming, carbon dioxide recovering, or air preheating, respectively if selected..
11/06/14
20140330043
 Hexafluorodimethylcarbinol terminated alkane- and alkenethiols patent thumbnailHexafluorodimethylcarbinol terminated alkane- and alkenethiols
A hexafluorodimethylcarbinol terminated compound, method of making it, and a composition of matter are disclosed. The compound may have the formula (cf3)2c(oh)-l-m-r.
11/06/14
20140329855
 Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide patent thumbnailSolid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
The present invention relates to solid state forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide (compound 1), pharmaceutical compositions thereof and methods therewith.. .
11/06/14
20140328784
 Hair conditioning cosmetic compositions containing a mixture of amidoamines patent thumbnailHair conditioning cosmetic compositions containing a mixture of amidoamines
Compositions are provided and described herein which include cosmetic and hair conditioning compositions having a mixture of stearamidopropyl dimethylamine and behenamidopropyl dimethylamine. Also provided are methods for conditioning hair using such mixtures..
11/06/14
20140328783
 Cosmetic composition comprising a supramolecular compound capable of establishing hydrogen bonds, and two particular distinct silicone oils patent thumbnailCosmetic composition comprising a supramolecular compound capable of establishing hydrogen bonds, and two particular distinct silicone oils
The present invention relates to a cosmetic composition comprising, in a cosmetically acceptable medium, at least: (a) a supramolecular compound that may be obtained by reaction between: —at least one oil bearing at least one nucleophilic reactive function chosen from oh and nh2, and —at least one junction group capable of establishing hydrogen bonds with one or more partner junction groups, each pairing of a junction group involving at least three hydrogen bonds, the said junction group bearing at least one isocyanate or imidazole reactive function capable of reacting with the reactive function borne by the oil, the said junction group also comprising at least one unit of formula (i) or (ii): (b) at least two distinct non-volatile silicone oils chosen from: i) phenyl silicone oils, in particular of formula (ii) or (vii) below: ii) linear or cyclic polydimethylsiloxanes (pdmss), iii) polydimethylsiloxanes comprising alkyl or alkoxy groups, which are pendent and/or at the end of the silicone chain, these groups each containing from 2 to 24 carbon atoms, and (d) at least one agent for structuring the liquid fatty phase.. .
11/06/14
20140325839
 Dimethyl ether (dme) enhanced gasoline engine patent thumbnailDimethyl ether (dme) enhanced gasoline engine
An engine having dme pilot ignition is disclosed. Dme pilot ignition creates far more energy than a conventional spark plug, thus minimizes the possibility of misfire in the engine map.
10/30/14
20140323591
 Water-based skin cosmetic patent thumbnailWater-based skin cosmetic
(b) a thickener composed of microgel obtained by using a composition that has an organic solvent or oil component as the dispersion medium and water as the dispersion phase, dissolving a water soluble ethylenically unsaturated monomer in the dispersion phase, and radically polymerizing it in the dispersion phase, wherein said microgel is obtained by radically polymerizing dimethylacrylamide and 2-acrylamido-2 methylpropane sulfonic acid under the conditions in which a single phase microemulsion or fine w/o emulsion is formed by using a surfactant.. .
10/30/14
20140323570
 Neuroprotection in demyelinating diseases patent thumbnailNeuroprotection in demyelinating diseases
Methods of treating neurological disorders characterized by extensive demyelination and/or axonal loss are provided. Examples of such disorders include secondary progressive multiple sclerosis and devic's disease.
10/30/14
20140323539
 Emulsifiable concentrate comprising pesticide, dimethyl sulfoxide, benzyl alcohol, alkyl lactate and diester patent thumbnailEmulsifiable concentrate comprising pesticide, dimethyl sulfoxide, benzyl alcohol, alkyl lactate and diester
Where r1 is c1-c8-alkyl and r2 is c2-c10-alkanediyl or c2-c10-alkenediyl. A further subject matter is an emulsion obtainable by mixing water with the emulsifiable concentrate; a process for the preparation of the emulsifiable concentrate; and a method for controlling phytopathogenic fungi and/or undesired vegetation and/or undesired attack by insects or mites and/or for regulating the growth of plants, where the concentrate or the emulsion is allowed to act on the respective pests, their environment or on the crop plants to be protected from the respective pests, on the soil and/or on undesired plants and/or on the crop plants and/or their environment..
10/30/14
20140323521
 Pharmaceutical compositions and administrations thereof patent thumbnailPharmaceutical compositions and administrations thereof
The present invention relates to the use of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide, solids forms, and pharmaceutical compositions thereof for the treatment of cftr mediated diseases, particularly cystic fibrosis, in patients possessing specific genetic mutations.. .
10/30/14
20140323506
Combination
The present invention relates to a method of treating cancer in a human and to pharmaceutical combinations useful in such treatment. In particular, the method relates to a cancer treatment method that includes administering 5-[[4-[(2,3-dimethyl-2h-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methylbenzenesulfonamide, or a pharmaceutically acceptable salt thereof, and n-{3-[3-cyclopropyl-5-(2-fluoro-4-iodo-phenylamino)6,8-dimethy;-2,4,7-trioxo-3,4,6,7-tetrahydro-2h-pyrido[4,3-d]pyrimidin-1-yl]phenyl}acetamide, or a pharmaceutically acceptable salt or solvate thereof, to a human in need thereof..
10/30/14
20140323387
5,5-dimethyl-2-propyl-hexahydro-2,4a-methano-naphthalen-1-one as a fragrance agent
As well as a composition comprising at least said compound of general formula (i), and its uses in perfumery.. .
10/30/14
20140322810
Natural and synthetic compounds for treating cancer and other diseases
This invention provides a method of synthesizing new active compounds for pharmaceutical uses including cancer treatment, wherein the cancers comprise breast, leukocytic, liver, ovarian, bladder, prostatic, skin, bone, brain, leukemia, lung, colon, cns, melanoma, renal, cervical, esophageal, testicular, spleenic, kidney, lymphatic, pancreatic, stomach and thyroid cancers. This invention is an anti-adhesion therapy which uses the compound as a mediator or inhibitor of adhesion proteins and angiopoietins.
10/30/14
20140322576
Lithium ion battery
A high-input and high-output battery having a large capacity while guaranteeing safety is provided. As a composition of an electrolytic solution, a composition ratio of ethylene carbonate (ec) is 20 vol % or more and 30 vol % or less, and a composition ratio of dimethyl carbonate (dmc) is 36 vol % or more and 50 vol % or less, and a composition ratio η (dmc/emc) of dimethyl carbonate (dmc) and ethyl methyl carbonate (emc) is 1.05≦η≦1.7.
10/30/14
20140319423
Sulfolane mixtures as ambient aprotic polar solvents
An improved solvent containing sulfolane and at least one dialkyl sulfone, preferably dimethyl sulfone, wherein the improved solvent is a liquid at room temperature and can be used for reaction media and electrochemistry.. .
10/23/14
20140316155
Methyl-substituted biphenyl compounds, their production and their use in the manufacture of plasticizers
In a process for producing methyl-substituted biphenyl compounds, a feed comprising at least one aromatic hydrocarbon selected from the group consisting of toluene, xylene and mixtures thereof is contacted with hydrogen in the presence of a hydroalkylation catalyst under conditions effective to produce a hydroalkylation reaction product comprising (methylcyclohexyl)toluenes and/or (dimethylcyclohexyl)xylenes together with dialkylated c21+ compounds. At least part of the dialkylated c21+ compounds is then removed from the hydroalkylation reaction product to produce a dehydrogenation feed; and at least part of the dehydrogenation feed is dehydrogenated in the presence of a dehydrogenation catalyst under conditions effective to produce a dehydrogenation reaction product comprising a mixture of methyl-substituted biphenyl compounds..
10/23/14
20140316004
Treatment of poultry for reducing the feed conversion rate or for reducing the incidence of ascites
Wherein r1 and r2 are independently an alkyl, an alkenyl or a hydroxyalkyl radical containing 1 to 18, preferably 1 to 6 carbon atoms or wherein r1 and r2 form jointly together with the n atom a heterocyclic 5- or 6-membered ring. The glycine compound is preferably n,n-dimethylglycine (dmg).
10/23/14
20140315948
Pharmaceutical composition and administrations thereof
The present invention relates to pharmaceutical compositions comprising a solid dispersion of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide, methods of manufacturing pharmaceutical compositions of the present invention, and methods of administering pharmaceutical compositions of the present invention.. .
10/23/14
20140315921
1-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-ht3 and 5-ht1a activity for the treatment of cognitive impairment
This disclosure relates to 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine or a pharmaceutically acceptable salt thereof in a crystalline form.. .
10/23/14
20140315127
Single component developer composition
Emulsion aggregation toner comprising: a resin; a wax; a colorant; an encapsulating shell; and a silica external additive comprising: first silica particles comprising fumed silica particles surface treated with octyldimethylsiloxane and having average particle diameter about 6-20 nm, present in amount of about 0.1-1% by weight of the toner; second silica particles comprising colloidal silica particles surface treated with hexamethyldisiloxane and having average particle diameter about 80-200 nm, present in amount of about 1-2% by weight of the toner; third silica particles comprising fumed silica particles surface treated with polydimethylsiloxane and having average particle diameter about 25-65 nm, present in amount of from about 0.5-1.5% by weight of the toner; and fourth silica particles comprising fumed silica particles surface treated with hexamethyldisiloxane and having average particle diameter about 25-65 nm, present in amount of about 1-2.5% by weight of the toner.. .
10/23/14
20140315119
Highly conductive anion-exchange composite membrane with crosslinked polymer electrolyte for alkaline fuel cell and method for preparing the same
Disclosed are a new method for preparing a highly conductive anion-exchange composite membrane with a crosslinked polymer electrolyte for an alkaline fuel cell and a composite membrane prepared by the same. The method includes (a) mixing (vinylbenzyl)trimethylammonium chloride, 1,3,5-triacryloylhexahydro-1,3,5-triazine, and a mixed solution of deionized water and dimethyl formamide at a weight ratio of 1:1 together by stirring at a weight ratio of 60˜75:5˜16:20˜25; (b) mixing 100 parts by weight of the mixed solution with 0.5 to 2 parts by weight of a photoinitiator; (c) impregnating a porous polymer support with the solution so that a monomer solution soaks into the support; (d) interposing an electrolyte-impregnated membrane between polyethylene terephthalate (pet) films and irradiating the electrolyte-impregnated membrane with ultraviolet (uv) light having an energy of 30 to 150 mj/cm2 for crosslinking; and (e) after the crosslinking step, removing the pet films, and removing by-products on the membrane surface and washing the membrane..
10/23/14
20140314884
Health supplement using guarana extract
The current invention is a supplement made from a combination of herbs, vitamins, amino acids which in the preferred embodiment is a 100% vegetarian liquid capsules that are ingested allow for rapid absorption. The components of the supplement can be mint or menthol such as peppermint or spearmint, methyl b12 or b12, niacin, guarana, dimethylaminoethanol, acetyl-l-carnitine or alcar, ocimum tenuiflorum, one or more teas such as green tea, white tea or black tea, ginkgo, rhodiola rosea, phosphatidylserine, tyrosine, l-alpha glycerylphosphorylcholine, citicoline (inn), huperzine a, and vinpocetine..
10/23/14
20140314720
Halogenated rhodamine derivatives and applications thereof
Methods for treating an infection in a tissue sample are described. Tissue samples that are harvested from a patient may be infected with either bacteria or a virus.
10/16/14
20140309311
Pharmaceutical combination
A pharmaceutical combination comprising as components (a) at least one 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol compound, and (b) at least one nmda-antagonist, a pharmaceutical formulation and a dosage form comprising such a combination, and a method of treating pain, e.g. Inflammatory pain or neuropathic pain, in which components (a) and (b) are administered simultaneously or sequentially to a mammal, with component (a) being administered either before or after component (b), and with components (a) or (b) being administered to the mammal either via the same pathway of administration or via different pathways of administration..
10/16/14
20140309243
Combination
The present invention relates to a method of treating cancer in a human and to pharmaceutical combinations useful in such treatment. In particular, the method relates to a cancer treatment method that includes administering n-{3-[3-cyclopropyl-5-(2-fluoro-4-iodo-phenylamino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydro-2h-pyrido[4,3-d]pyrimidin-1-yl]phenyl}acetamide, or a pharmaceutically acceptable salt or solvate thereof, and n-{(1s)-2-amino-1-[(3-fluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1h-pyrazol-5-yl)-2-thiophenecarboxamide, or a pharmaceutically acceptable salt thereof, to a human in need thereof..
10/16/14
20140308438
Composition and method of application to reduce magnetostriction losses in encapsulated microelectronic components
A buffer material protects a microelectronic device in space constrained environments, for improved efficiency with respect to magnetostrictive materials therein, and includes a gas filled polymer shell microsphere carried in an elastomeric polymer binder. Expanded expancel microspheres being less than 20 microns in diameter form 80% of the composition by volume.
10/16/14
20140308244
Combination therapy for treatment of inflammatory demyelinating disease
Provided herein include combination therapies for the treatment of neurological inflammatory diseases, such as, for example, demyelinating autoimmune diseases, such as multiple sclerosis and neuromyelitis optica, etc. In various aspects and embodiments, the methods may include administering to a patient an effective dose of an inhibitor of an angiotensin-converting enzyme (ace) in combination with one or more second compounds, in one aspect, provided is a method of treating a demyelinating autoimmune disease (such as multiple sclerosis) that includes administering to a patient an effective dose of an inhibitor of an angiotensin-converting enzyme (ace) in combination with one or more compounds selected from the group consisting of a cytokine, a vitamin b, dimethyl fumarate (dmf, also referred to as bg-12) and fingolimod (gilenya)..
10/16/14
20140305842
Process for upgrading a high endpoint gas oil containing high concentrations of thiophenes and nitrogen and providing for a reduced hydrogen consumption rate.
A process and catalyst that provides for the upgrading of a high endpoint gas oil feedstock that contains significant concentrations of organic sulfur compound and organic nitrogen compounds. Included among the sulfur compounds are the dimethyl-dibenzothiophenes and derivative thereof.
10/09/14
20140303323
Methods for preparation of polyester/glyoxalated polyvinyl alcohol semi-interpenetrating polymer network hot-melt adhesive
A polyester/glyoxalated polyvinyl alcohol semi-interpenetrating polymer network hot-melt adhesive and preparation method therefore, mainly inlcudes the steps of: 1) transesterification of certain amounts of dimethyl terephthalate and another dibasic ester with 1,4-butanediol and other diols in the presence of an organotin catalyst under a nitrogen atmosphere in a reactor, completed upon the amount of distillation of a monohydric alcohol byproduct reaching greater than 95% of the theoretical amount; 2) after the temperature is maintained for a period of time, adding in a stabilizer and a polycondensation catalyst and incrementally increasing the temperature to trigger a polycondensation reaction under a reduced pressure to produce particles of a copolymer, and freezing and pulverizing the copolymer particles to produce a powder of a copolyester; 3) uniformly blending a polyvinyl alcohol/glyoxal mixture with the powder produced in step 2) at ambient temperature to produce the target product. The product is capable of forming an internal semi-interpenetrating network at application temperatures..
10/09/14
20140303265
Demulsification compositions, systems and methods for demulsifying and separating aqueous emulsions
The present invention provides compositions, systems and methods for demulsifying an emulsion including an aqueous phase and an organic phase by adding an effective amount of a composition comprising at least one quaternary organopolysiloxane or salt thereof to the emulsion, the composition optionally including at least one of quaternary epihalohydrin/polyamine copolymers or salts, and/or (poly)diallyldimethylammonium halides.. .
10/09/14
20140303195
Combination
A novel combination comprising the mek inhibitor n-{3-[3-cyclopropyl-5-(2-fluoro-4-iodo-phenylamino)6,8-dimethyl;-2,4,7-trioxo-3,4,6,7-tetrahydro-2h-pyrido[4,3-d]pyrimidin-1-yl]phenyl}acetamide, or a pharmaceutically acceptable salt or solvate thereof, with a mtor inhibitor, pharmaceutical compositions comprising the same and methods of using such combinations and compositions in the treatment of conditions in which the inhibition of mek and/or mtor is beneficial, e.g. Cancer..
10/09/14
20140303052
Thickened grease composition
A thickened grease composition is provided by process of heating a mineral oil and 12-hydroxystearic acid with lithium hydroxide and forming a simple lithium grease to which at least one component selected from the group comprising succinic acid, glutaric acid, adipic acid, 6-hydroxycaproic acid, dimethyl succinate, dimethyl glutarate, dimethyl adipate, methyl hydroxycaproate, cyclohexanediols, methyl 5-hydroxyvalerate, methyl valerate, gamma butyrolactone, and methyl levulinate or mixtures thereof.. .
10/09/14
20140302174
Combination therapy for ovarian cancer
The present invention provides a method of treating ovarian cancer in a mammal in need of such treatment comprising administering an effective amount of a combination of gemcitabine, cisplatin or carboplatin, and 5-[2-tert-butyl-5-(4-fluoro-phenyl)-1h-imidazol-4-yl]-3-(2,2-dimethyl-propyl)-3h-imidazo[4,5-b]pyridin-2-ylamine.. .
10/09/14
20140301957
Enamel protectant and repair brushing gels
Substantially aqueous-free, enamel protectant and repair brushing gels containing: stannous fluoride, calcium and a substantivity agent comprising: an emulsion of polydimethylsiloxane in a nonionic surfactant, wherein substantivity of said stannous fluoride and calcium into biofilm present on enamel is enhanced through calcium binding shifting from bidentate to monodentate in the presence of stannous fluoride; and said brushing gels have substantially improved, enamel protectant factor (epf) and enamel repair factor (erf) values compared to fluoride brushing treatments with comparable or higher fluoride levels.. .
10/09/14
20140301956
Methods for protecting and reparing enamel
A method of treatment for enamel with substantially aqueous-free, enamel protectant and repair brushing gels containing: stannous fluoride, calcium and a substantivity agent comprising: an emulsion of polydimethylsiloxane in a nonionic surfactant, wherein substantivity of said stannous fluoride and calcium into biofilm present on enamel is enhanced through calcium binding shifting from bidentate to monodentate in the presence of stannous fluoride; and said brushing gels have substantially improved, enamel protectant factor (epf) and enamel repair factor (erf) values compared to fluoride brushing treatments with comparable or higher fluoride levels.. .
10/09/14
20140299021
Non-aqueous solvent composition and its use as barrier liquid
A non-aqueous solvent composition comprising 0 to 10 wt. % of n-alkyl pyrrolidone, 0 to 5 wt.
10/02/14
20140296600
Production of para-xylene by catalytically reacting 2,5-dimethylfuran and ethylene in a solvent
The present invention provides a renewable route to para-xylene via cycloaddition of ethylene and 2,5-dimethylfuran and subsequent dehydration with high selectivity and high yields using acidic heterogeneous catalysts and a solvent for 2,5-dimethylfuran. The use of a solvent shows significant effects in the reduction of competing side reactions including hydrolysis of 2,5-dimethylfuran to 2,5-hexanedione, alkylation of p-xylene, and polymerization of 2,5-hexanedione..
10/02/14
20140296573
Method of making a templating agent
A method for preparing 1-adamantyltrimethylammonium hydroxide is disclosed. The method comprises reacting 1-adamantyldimethylamine with dimethyl carbonate to produce 1-adamantyltrimethylammonium methylcarbonate, which is then reacted with calcium hydroxide or magnesium hydroxide in the presence of water to produce 1-adamantyltrimethylammonium hydroxide..
10/02/14
20140296425
Telechelic based networks from novel macromonomers, compositions, preparation and uses thereof
The invention provides highly resilient synthetic hydrogels, which can be prepared, for example, by using the efficient thiol-norbornene chemistry to cross-link hydrophilic poly(ethylene glycol) (peg) and hydrophobic polydimethylsiloxane (pdms) polymer chains. The simple hydrogel system with enhanced mechanical properties is useful in many applications, including in the biomedical field and in the design of protective and corrective wear..
10/02/14
20140296422
Resin composition and molded body
Provided is a resin composition having weather resistance and low-temperature impact resistance, which are the problems of a poly(1,4-cyclohexylene dimethylene terephthalate) copolyester resin, and sustaining the chemical resistance and room-temperature impact resistance of poly(1,4-cyclohexylene dimethylene terephthalate) copolyester resin. It is a resin composition containing a poly(1,4-cyclohexylene dimethylene terephthalate) copolyester resin and a polycarbonate resin, in which the poly(1,4-cyclohexylene dimethylene terephthalate) copolyester resin is contained at 60 to 95% by weight and the polycarbonate resin is contained at 5 to 40% by weight..
10/02/14
20140296346
Crystalline forms of (-)-(1r,2r)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenol hydrochloride
A hitherto unknown crystalline form of (-)-(1r,2r)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenol hydrochloride, pharmaceutical compositions containing the new crystalline form, methods of producing the new crystalline form, and a related method of use including treatment of, e.g., pain and/or urinary incontinence.. .
10/02/14
20140296267
Solid dispersions of a erb2 (her2) inhibitor
A solid dispersion of n4-(4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)-n6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine and processes for preparing the solid dispersion are provided herein. Also, a pharmaceutical composition comprising a solid dispersion of n4-(4-([1,2,4]triazolo[1,5-α]pyridin-7-yloxy)-3-methylphenyl)-n6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine and uses thereof are provided herein..
10/02/14
20140296213
New polymorph
The invention provides a new polymorph of 1-(2-methyl-4-(2,3,4,5-tetrahydro-1-benzazepin-1-ylcarbonyl)benzyl-carbamoyl)-l-proline-n,n-dimethylamide, pharmaceutical compositions containing it and its use in therapy.. .
10/02/14
20140295449
Screening method for selected amino lipid-containing compositions
The invention features a method of identifying therapeutically relevant compositions which include a therapeutic agent and 2,2-dilinoley 1-4-dimethylaminomethyl-[1,3]-dioxolane by screening for an effect of the agent on the liver of a model subject.. .
10/02/14
20140294741
Enamel protectant and repair toothpaste treatments
Substantially aqueous-free, enamel protectant and enamel repair toothpaste treatments containing: stannous fluoride, calcium and a substantivity agent comprising: an emulsion of polydimethylsiloxane in a nonionic surfactant, wherein: (a) substantivity of said stannous fluoride and calcium into biofilm present on enamel is enhanced through calcium binding shifting from bidentate to monodentate in the presence of stannous fluoride; and (b) said toothpaste treatments indicate substantially improved, enamel protectant factor (epf) and enamel repair factor (erf) values compared to fluoride brushing treatments with comparable or higher fluoride levels.. .
10/02/14
20140294032
Solid-state dye laser medium and process for production thereof
The challenge of providing a long-life solid-state dye laser medium is tackled. This challenge is solved by a solid-state dye laser medium comprising a polydimethylsiloxane, and a dye dissolved in the polydimethylsiloxane.
09/25/14
20140288307
Crystalline cis-(e)-4-(3-fluorophenyl)-2',3',4',9'-tetrahydro-n,n-dimethyl-2'-(1-oxo-3-phenyl-2-propenyl)-spiro[cyclohexane-1,1'[1h]-pyrido[3,4-b]indol]-4-amine
The present invention relates to crystalline forms of cis-(e)-4-(3-fluorophenyl)-2′,3′,4′,9′-tetrahydro-n,n-dimethyl-2′-(1-oxo-3-phenyl-2-propenyl)-spiro[cyclohexane-1,1′[1h]-pyrido[3,4-b]indol]-4-amine, pharmaceutical compositions and medicaments comprising these modifications, the use of these modifications as well as to a process for making the crystalline forms.. .
09/25/14
20140287011
Arthropod pest control composition
Disclosed is an arthropod pest control composition comprising 2-(2,6-difluorophenyl)-4-[4-(1,1-dimethylethyl)-2-ethoxyphenyl]-4,5-dihydrooxazole and an inert carrier, wherein the volume median diameter of 2-(2,6-difluorophenyl)-4-[4-(1,1-dimethylethyl)-2-ethoxyphenyl]-4,5-dihydrooxazole is from 1.5 to 5.9. .
09/25/14
20140284245
Pharmaceutical compositions of dimethyl fumarate
Pharmaceutical compositions and dosage forms of dimethyl fumarate containing low levels of certain impurities are disclosed.. .
09/25/14
20140283982
Universal nanopatternable interfacial bonding
One embodiment of the present invention provides a system for bonding a first substrate and a second substrate. During operation, the system starts by treating a first surface of the first substrate and a second surface of the second substrate with a hydrophilic treatment.
09/18/14
20140275683
Catalyst for preparing isobutene by dissociation of methyl tert-butyl ether, preparation method and use thereof
Disclosed is a catalyst for preparing isobutene by dissociation of methyl tert-butyl ether, the catalyst comprising amorphous silica alumina and a silicalite-1 molecular sieve, wherein the total ir acid amount of weak acids in the catalyst is in a range from 0.020 to 0.080 mmol/g, and the ratio of b acid/l acid of the weak acids is in a range from 2.5:1 to 4.0:1. Also provided is a method of preparing the catalyst and the use thereof.
09/18/14
20140275609
Methyl-substituted biphenyl compounds, their production and their use in the manufacture of plasticizers
In a process for producing methyl-substituted biphenyl compounds, a feed comprising at least one aromatic hydrocarbon selected from the group consisting of toluene, xylene and mixtures thereof is contacted with hydrogen in the presence of a hydroalkylation catalyst under conditions effective to produce a hydroalkylation reaction product comprising (methylcyclohexyl)toluenes and/or (dimethylcyclohexyl)xylenes. At least part of the hydroalkylation reaction product is then dehydrogenated in the presence of a dehydrogenation catalyst under conditions effective to produce a dehydrogenation reaction product comprising a mixture of methyl-substituted biphenyl compounds..
09/18/14
20140275538
Rilpivirine process
Disclosed is process for the preparation of a key rilpivirine intermediate namely, (e)-4-(2-cyanoethenyl)-2,6-dimethylphenylamine hydrochloride (ii) by a process comprising reaction of the tetrafluoroborate salt of the diazonium ion of 2,6-dimethyl-4-amino-1-carboxybenzyl phenylamine (vi) with acrylonitrile in presence of palladium acetate, followed by treatment with an acid and its subsequent conversion to the hydrochloride salt (ii), wherein the undesired z isomer is less than 0.5% and provides rilpivirine hydrochloride having z isomer less than 0.1%.. .
09/18/14
20140275291
Biocompatible and bioabsorbable derivatized chitosan compositions
The invention relates to biocompatible, bioabsorbable derivatized non-crosslinked chitosan compositions optionally crosslinked to gelatin/collagen by 1-ethyl-3-[3-dimethylaminopropyl]carbodiimide hydrochloride (edc) for biomedical use and methods of making and testing such compositions, including a modified acute systemic toxicity test. The compositions comprise derivatized chitosan reacetylated to a degree of n-deacetylation (dda) of between about 15% and 40%.
09/18/14
20140275190
Biocidal composition of 2,6-dimethyl-m-dioxane-4-ol acetate and methods of use
Provided is a biocidal composition comprising 2,6-dimethyl-m-dioxane-4-ol acetate and an isothiazolinone biocidal compound. The composition is useful for controlling microorganisms in aqueous or water containing systems..
09/18/14
20140275105
Crystal of androgen receptor antagonistic compound
[solution] a01-type crystal of monohydrate, a01-type crystal of hydrochloride, a01-type crystal of hydrobromide, and a01-type crystal of methanesulfonate of (2r,5s)-4-(3-chloro-4-cyanophenyl)-n-(2-cyclopropylpyrimidin-5-yl)-2,5-dimethylpiperazine-1-carboxamide, which have certain crystal forms, are provided.. .


Popular terms: [SEARCH]

Dimethyl topics: Physiologic, Hydrochloric Acid, Fresnel Zone, Aberration, Ophthalmic, Liquid Crystal, Imaging System, Pharmaceutically Acceptable Salt, Pharmaceutically Acceptable Salts, Chloric Acid, Tartaric Acid, Fumaric Acid, Antagonist, Bradykinin, Enantiomer

Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to Dimethyl for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Dimethyl with additional patents listed. Browse our RSS directory or Search for other possible listings.
     SHARE
  
         


FreshNews promo



0.2578

3319

2 - 1 - 73